Nucleotide and cellular vaccine composition

Details for Australian Patent Application No. 2004227821 (hide)

Owner Huang, M.

Inventors Huang, Mallen

Agent Collison & Co

Pub. Number AU-A-2004227821

PCT Pub. Number WO2004/089413

Priority 0301109-5 14.04.03 SE

Filing date 14 April 2004

Wipo publication date 21 October 2004

International Classifications

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups

A61P 035/00 Antineoplastic agents

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 039/00 Medicinal preparations containing antigens or antibodies

A61P 037/02 Drugs for immunological or allergic disorders

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089413 Priority application(s): WO2004/089413

27 October 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Nucleotide vaccine composition.

12 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227826-Method and a composite for mercury capture from fluid streams

2004227818-A device for use in a cartridge, and a cartridge